U.S. Pharmaceuticals & Biotech High Growth Stocks

Zevra Therapeutics

Market Cap: US$715.0m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Arcutis Biotherapeutics

Market Cap: US$3.1b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Kiniksa Pharmaceuticals International

Market Cap: US$6.3b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Sotera Health

Market Cap: US$5.6b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.